Related references
Note: Only part of the references are listed.The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model
M. Hamdi Muz et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2006)
Targeted immunomodulation of the NF-κB pathway in airway epithelium impacts host defense against Pseudomonas aeruginosa
Ruxana T. Sadikot et al.
JOURNAL OF IMMUNOLOGY (2006)
NF-kappa B and activator protein 1 response elements and the role of histone modifications in IL-1-beta-induced TGF-beta 1 gene transcription
KY Lee et al.
JOURNAL OF IMMUNOLOGY (2006)
NF-κB activation in airways modulates allergic inflammation but not hyperresponsiveness
ME Poynter et al.
JOURNAL OF IMMUNOLOGY (2004)
Selective blockade of NF-κB activity in airway immune cells inhibits the effector phase of experimental asthma
C Desmet et al.
JOURNAL OF IMMUNOLOGY (2004)
Urokinase potentiates PDGF-induced chemotaxis of human airway smooth muscle cells
SM Carlin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)
Nuclear factor-κB activation in alveolar macrophages requires Iκkinase-β, but not nuclear factor-κB inducing kinase
M Conron et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma
SH Cho et al.
JOURNAL OF IMMUNOLOGY (2000)
Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator
H Shirota et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
